Professor Xiao Yan has been engaged in hospital pharmacy since graduation. He is currently the deputy director and director of the Pharmacy Department of Daqing Oilfield General Hospital, director of Heilongjiang Pharmaceutical Society, member of the Pharmaceutical Professional Committee of Heilongjiang Pharmaceutical Society, deputy secretary general of Daqing Pharmaceutical Society, and adjunct professor of Jiamusi University. Main academic achievements: Since 2002, he has published four papers 14 and two books, and completed provincial, municipal, administrative and college-level scientific research 15.
1, "Optimization of extraction and separation conditions of rhubarb effective components" was published in China Journal of Clinical Pharmacology and Therapeutics, Vol.8, No.98 1 issue, February 2003.
2. The effect of recombinant human granulocyte colony-stimulating factor on preventing infection in patients with malignant tumor during chemotherapy was published in China Journal of Biological Products (2003), Vol. 16, No.2 1 19.
3. The study on the anti-tumor effect of Fuzheng Luo Qing Capsule combined with cyclophosphamide on S 180 was published in China Pharmacy, No.4, 2004 15, Volume 2 10.
4. Re-discussion on the therapeutic window concentration of digoxin was published in China Pharmacy in 2005, Volume 16, Issue 14, Page 108 1.
5. The research and development progress of Taxus chinensis and Taxol was published on page 34 of China Medical Information, Volume 22, No.4, 2005.
6. The Cost-Effectiveness Analysis of Three Chemotherapy Schemes for Breast Cancer was published in chinese journal of modern applied pharmacy Journal.
14, Cost-effectiveness analysis of three treatment schemes for pneumonia in children was published in Evaluation and Analysis of Drug Use in China Hospitals, Vol.6, No.4, 2006, p.233.